text:
Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function: an exploratory analysis of JCOG1113
the members of the Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG).
JCOG1113 is a randomized phase III trial in patients with advanced biliary tract cancers (BTCs) (UMIN000001685), and gemcitabine plus S-1 (GS) was not inferior to gemcitabine plus cisplatin (GC). However, poor renal function often results in high toxicity of S-1. Therefore, we examined whether GS can be recommended for patients with low creatinine clearance (CCr). Renal function was classified by CCr as calculated by the Cockcroft-Gault formula: high CCr (CCr ≥ 80 ml/min) and low CCr (80 > CCr ≥ 50 ml/min). Of 354 patients, 87 patients on GC and 91 on GS were included in the low CCr group, while there were 88 patients on GC and 88 patients on GS in the high CCr group. The HR of overall survival for GS compared with GC was 0.687 (95% CI 0.504–0.937) in the low CCr group. Although the total number of incidences of all Grade 3–4 non-haematological adverse reactions was higher (36.0% vs. 11.8%, p = 0.0002), the number of patients who discontinued treatment was not different (14.1% vs. 16.9%, p = 0.679) for GS compared with GC in the low CCr group. This study suggests that GS should be selected for the treatment of advanced BTC patients with reduced renal function.
論文番号
出版済み - 12 2021
この成果は、次の持続可能な開発目標に貢献しています
「Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function: an exploratory analysis of JCOG1113」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。
Biliary Tract Neoplasms Medicine & Life Sciences 100%
gemcitabine Medicine & Life Sciences 78%
Cisplatin Medicine & Life Sciences 26%
the members of the Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). (2021). Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function: an exploratory analysis of JCOG1113. Scientific reports, 11(1), [12885]. https://doi.org/10.1038/s41598-021-92166-3
Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function : an exploratory analysis of JCOG1113. / the members of the Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG).
In: Scientific reports, Vol. 11, No. 1, 12885, 12.2021.
the members of the Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). 2021, 'Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function: an exploratory analysis of JCOG1113', Scientific reports, vol. 11, no. 1, 12885. https://doi.org/10.1038/s41598-021-92166-3
the members of the Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function: an exploratory analysis of JCOG1113. Scientific reports. 2021 12;11(1). 12885. https://doi.org/10.1038/s41598-021-92166-3
the members of the Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). / Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function : an exploratory analysis of JCOG1113. In: Scientific reports. 2021 ; Vol. 11, No. 1.
@article{6c473738789f4d7895f8b317674c6de0,
title = "Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function: an exploratory analysis of JCOG1113",
abstract = "JCOG1113 is a randomized phase III trial in patients with advanced biliary tract cancers (BTCs) (UMIN000001685), and gemcitabine plus S-1 (GS) was not inferior to gemcitabine plus cisplatin (GC). However, poor renal function often results in high toxicity of S-1. Therefore, we examined whether GS can be recommended for patients with low creatinine clearance (CCr). Renal function was classified by CCr as calculated by the Cockcroft-Gault formula: high CCr (CCr ≥ 80 ml/min) and low CCr (80 > CCr ≥ 50 ml/min). Of 354 patients, 87 patients on GC and 91 on GS were included in the low CCr group, while there were 88 patients on GC and 88 patients on GS in the high CCr group. The HR of overall survival for GS compared with GC was 0.687 (95% CI 0.504–0.937) in the low CCr group. Although the total number of incidences of all Grade 3–4 non-haematological adverse reactions was higher (36.0% vs. 11.8%, p = 0.0002), the number of patients who discontinued treatment was not different (14.1% vs. 16.9%, p = 0.679) for GS compared with GC in the low CCr group. This study suggests that GS should be selected for the treatment of advanced BTC patients with reduced renal function.",
author = "{the members of the Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG).} and Makoto Ueno and Chigusa Morizane and Takuji Okusaka and Junki Mizusawa and Tomoko Kataoka and Masafumi Ikeda and Masato Ozaka and Naohiro Okano and Kazuya Sugimori and Akiko Todaka and Satoshi Shimizu and Nobumasa Mizuno and Tomohisa Yamamoto and Keiji Sano and Kazutoshi Tobimatsu and Akio Katanuma and Atsushi Miyamoto and Hironori Yamaguchi and Tomohiro Nishina and Hirofumi Shirakawa and Yasushi Kojima and Takamasa Oono and Yasuyuki Kawamoto and Masayuki Furukawa and Tomohisa Iwai and Kentaro Sudo and Hiroyuki Miyakawa and Tatsuya Yamashita and Ichirou Yasuda and Hidenori Takahashi and Naoya Kato and Kazuhiko Shioji and Kyoko Shimizu and Toshio Nakagohri and Ken Kamata and Hiroshi Ishii and Junji Furuse",
note = "Funding Information: Dr. Ueno reports grants and personal fees from Yakult Honsha, grants and personal fees from Taiho Pharmaceutical, AstraZeneca, Merck Serono, MSD, Daiichi Sankyo and Ono Pharmaceutical, personal fees from Nihon Servier, grants from Astellas Pharma, Eisai, Sumitomo Dainippon Pharma and Incyte. Dr. Morizane reports grants and personal fees from Yakult Honsha, J-Pharma, AstraZeneca, MSD and Taiho Pharmaceutical, grants from Eisai, Merck Biopharma and Ono Pharmaceutical, personal fees from Teijin Pharma, Novartis and Abbvie. Dr. Okusaka reports grants and personal fees from Eli Lilly, Taiho Pharmaceutical, Pfizer Japan and Yakult Honsha, personal fees from Meiji Seika Pharma, grants and personal fees from Ono Pharmaceutical, Eisai, Sumitomo Dainippon Pharma, Bristol-Myers Squibb, Bayer Yakuhin, Chugai Pharmaceutical, Zeria Pharmaceutical, Daiichi Sankyo and MSD, grants from Kyowa Hakko Kirin, NanoCarrier and Baxter, personal fees from EA Pharma, FUJIFILM RI Pharma, Celgene, Teijin Pharma, Shire, AbbVie, Takeda Pharmaceutical, Mundipharma, Nihon Servier and Nippon Shinyaku. Mr. Mizusawa reports grants from the Ministry of Health, Labour and Welfare, Japan and Japan Agency for Medical Research and Development (AMED), personal fees from Chugai Pharmaceutical. Dr. Ikeda reports grants from Yakult Honsha, Ono Pharmaceutical, AstraZeneca, J-Pharma, Merck Serono, Bristol-Myers Squibb, Pfizer, Takeda Pharmaceutical and Chiome Bioscience, personal fees and grants from ASLAN, Nihon Servier, NanoCarrier, Novartis, Bayer Yakuhin, Eli Lilly, MSD and Chugai Pharmaceutical, personal fees from Taiho Phamaceutical, Sumitomo Dainippon Pharma, Teijin Pharma, Mylan, Astellas Pharma, EA Pharma, Shire, Gilead and Otsuka. Dr. Okano reports personal fees from Taiho Pharmaceutical, Eli Lilly Japan, Kyowa Hakko Kirin, Eisai, Bayer Yakuhin, Chugai Pharmaceutical, J-Pharma, Ono Pharmaceutical, Takeda Pharmaceutical and Merck BioPharma. Dr. Shimizu reports grants from Sumitomo Dainippon Pharma, Yakult Honsha, Incyte and AstraZeneca. Dr. Mizuno reports grants and personal fees from Taiho Pharmaceutical, grants from the Ministry of Health, Labour and Welfare, Japan, grants and personal fees from Novartis, AstraZeneca, MSD and Yakult Honsha, grants from NanoCarrier, Eisai, Sumitomo Dainippon Pharma, ASLAN Pharmaceuticals, Incyte and Ono Pharmaceutical, personal fees from Teijin Pharma. Dr. Takahashi reports grants from Taiho Pharmaceutical. Dr. Ishii reports personal fees from Ono Pharmaceutical, Yakult Honsha, Taiho Pharmaceutical, Eli Lilly Japan and Teijin Pharma. Dr. Furuse reports grants from the National Cancer Center Research and Development Fund and a Grant-in-Aid for Clinical Cancer Research from the Ministry of Health, Labour and Welfare of Japan, personal fees from Eisai, Bayer Yakuhin, Taiho Pharmaceutical, Ono Pharmaceutical, Novartis, Yakult Honsha, Teijin pharma, Shionogi, EA Pharma, Eli Lilly Japan, Takeda Pharmaceutical, Chugai Pharmaceutical, Mochida Pharmaceutical, Nihon Servier, Sanofi, Fujifilm Toyama Chemical, Nobelpharma, Pfizer, Sawai Pharmaceutical, Daiichi Sankyo, Sumitomo Dainippon Pharma, Merck Serono, Nippon Kayaku, MSD, Shire and Kyowa Hakko Kirin, grants from Ono Pharmaceutical, MSD, Sumitomo Dainippon Pharma, J-Pharma, Yakult Honsha, AstraZeneca, Daiichi Sankyo, Eisai, Bayer Yakuhin, Pfizer, NanoCarrier, Kyowa Hakko Kirin, Taiho Pharmaceutical, Chugai Pharmaceutical, Sanofi, Takeda Pharmaceutical, Mochida Pharmaceutical, Astel-las Pharma and Eli Lilly Japan. All other authors declare no conflicts of interest in relation to the present work. Funding Information: This work was supported by the National Cancer Center Research and Development Fund (grant numbers 23-A-22, 26-A-4, 29-A-3, 2020-J-3), the Japan Agency for Medical Research and Development (grant numbers JP16ck0106079 and JP19ck0106350), and a Grant-in-Aid for Clinical Cancer Research (H22-ganrinsho-ippan-013) from the Ministry of Health, Labour and Welfare of Japan. Publisher Copyright: {\textcopyright} 2021, The Author(s).",
T1 - Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function
T2 - an exploratory analysis of JCOG1113
AU - the members of the Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG).
AU - Ueno, Makoto
AU - Morizane, Chigusa
AU - Okusaka, Takuji
AU - Mizusawa, Junki
AU - Kataoka, Tomoko
AU - Ikeda, Masafumi
AU - Ozaka, Masato
AU - Okano, Naohiro
AU - Sugimori, Kazuya
AU - Todaka, Akiko
AU - Shimizu, Satoshi
AU - Mizuno, Nobumasa
AU - Yamamoto, Tomohisa
AU - Sano, Keiji
AU - Tobimatsu, Kazutoshi
AU - Katanuma, Akio
AU - Miyamoto, Atsushi
AU - Yamaguchi, Hironori
AU - Nishina, Tomohiro
AU - Shirakawa, Hirofumi
AU - Kojima, Yasushi
AU - Oono, Takamasa
AU - Kawamoto, Yasuyuki
AU - Furukawa, Masayuki
AU - Iwai, Tomohisa
AU - Sudo, Kentaro
AU - Miyakawa, Hiroyuki
AU - Yamashita, Tatsuya
AU - Yasuda, Ichirou
AU - Takahashi, Hidenori
AU - Kato, Naoya
AU - Shioji, Kazuhiko
AU - Shimizu, Kyoko
AU - Nakagohri, Toshio
AU - Kamata, Ken
AU - Ishii, Hiroshi
AU - Furuse, Junji
N1 - Funding Information: Dr. Ueno reports grants and personal fees from Yakult Honsha, grants and personal fees from Taiho Pharmaceutical, AstraZeneca, Merck Serono, MSD, Daiichi Sankyo and Ono Pharmaceutical, personal fees from Nihon Servier, grants from Astellas Pharma, Eisai, Sumitomo Dainippon Pharma and Incyte. Dr. Morizane reports grants and personal fees from Yakult Honsha, J-Pharma, AstraZeneca, MSD and Taiho Pharmaceutical, grants from Eisai, Merck Biopharma and Ono Pharmaceutical, personal fees from Teijin Pharma, Novartis and Abbvie. Dr. Okusaka reports grants and personal fees from Eli Lilly, Taiho Pharmaceutical, Pfizer Japan and Yakult Honsha, personal fees from Meiji Seika Pharma, grants and personal fees from Ono Pharmaceutical, Eisai, Sumitomo Dainippon Pharma, Bristol-Myers Squibb, Bayer Yakuhin, Chugai Pharmaceutical, Zeria Pharmaceutical, Daiichi Sankyo and MSD, grants from Kyowa Hakko Kirin, NanoCarrier and Baxter, personal fees from EA Pharma, FUJIFILM RI Pharma, Celgene, Teijin Pharma, Shire, AbbVie, Takeda Pharmaceutical, Mundipharma, Nihon Servier and Nippon Shinyaku. Mr. Mizusawa reports grants from the Ministry of Health, Labour and Welfare, Japan and Japan Agency for Medical Research and Development (AMED), personal fees from Chugai Pharmaceutical. Dr. Ikeda reports grants from Yakult Honsha, Ono Pharmaceutical, AstraZeneca, J-Pharma, Merck Serono, Bristol-Myers Squibb, Pfizer, Takeda Pharmaceutical and Chiome Bioscience, personal fees and grants from ASLAN, Nihon Servier, NanoCarrier, Novartis, Bayer Yakuhin, Eli Lilly, MSD and Chugai Pharmaceutical, personal fees from Taiho Phamaceutical, Sumitomo Dainippon Pharma, Teijin Pharma, Mylan, Astellas Pharma, EA Pharma, Shire, Gilead and Otsuka. Dr. Okano reports personal fees from Taiho Pharmaceutical, Eli Lilly Japan, Kyowa Hakko Kirin, Eisai, Bayer Yakuhin, Chugai Pharmaceutical, J-Pharma, Ono Pharmaceutical, Takeda Pharmaceutical and Merck BioPharma. Dr. Shimizu reports grants from Sumitomo Dainippon Pharma, Yakult Honsha, Incyte and AstraZeneca. Dr. Mizuno reports grants and personal fees from Taiho Pharmaceutical, grants from the Ministry of Health, Labour and Welfare, Japan, grants and personal fees from Novartis, AstraZeneca, MSD and Yakult Honsha, grants from NanoCarrier, Eisai, Sumitomo Dainippon Pharma, ASLAN Pharmaceuticals, Incyte and Ono Pharmaceutical, personal fees from Teijin Pharma. Dr. Takahashi reports grants from Taiho Pharmaceutical. Dr. Ishii reports personal fees from Ono Pharmaceutical, Yakult Honsha, Taiho Pharmaceutical, Eli Lilly Japan and Teijin Pharma. Dr. Furuse reports grants from the National Cancer Center Research and Development Fund and a Grant-in-Aid for Clinical Cancer Research from the Ministry of Health, Labour and Welfare of Japan, personal fees from Eisai, Bayer Yakuhin, Taiho Pharmaceutical, Ono Pharmaceutical, Novartis, Yakult Honsha, Teijin pharma, Shionogi, EA Pharma, Eli Lilly Japan, Takeda Pharmaceutical, Chugai Pharmaceutical, Mochida Pharmaceutical, Nihon Servier, Sanofi, Fujifilm Toyama Chemical, Nobelpharma, Pfizer, Sawai Pharmaceutical, Daiichi Sankyo, Sumitomo Dainippon Pharma, Merck Serono, Nippon Kayaku, MSD, Shire and Kyowa Hakko Kirin, grants from Ono Pharmaceutical, MSD, Sumitomo Dainippon Pharma, J-Pharma, Yakult Honsha, AstraZeneca, Daiichi Sankyo, Eisai, Bayer Yakuhin, Pfizer, NanoCarrier, Kyowa Hakko Kirin, Taiho Pharmaceutical, Chugai Pharmaceutical, Sanofi, Takeda Pharmaceutical, Mochida Pharmaceutical, Astel-las Pharma and Eli Lilly Japan. All other authors declare no conflicts of interest in relation to the present work. Funding Information: This work was supported by the National Cancer Center Research and Development Fund (grant numbers 23-A-22, 26-A-4, 29-A-3, 2020-J-3), the Japan Agency for Medical Research and Development (grant numbers JP16ck0106079 and JP19ck0106350), and a Grant-in-Aid for Clinical Cancer Research (H22-ganrinsho-ippan-013) from the Ministry of Health, Labour and Welfare of Japan. Publisher Copyright: © 2021, The Author(s).
N2 - JCOG1113 is a randomized phase III trial in patients with advanced biliary tract cancers (BTCs) (UMIN000001685), and gemcitabine plus S-1 (GS) was not inferior to gemcitabine plus cisplatin (GC). However, poor renal function often results in high toxicity of S-1. Therefore, we examined whether GS can be recommended for patients with low creatinine clearance (CCr). Renal function was classified by CCr as calculated by the Cockcroft-Gault formula: high CCr (CCr ≥ 80 ml/min) and low CCr (80 > CCr ≥ 50 ml/min). Of 354 patients, 87 patients on GC and 91 on GS were included in the low CCr group, while there were 88 patients on GC and 88 patients on GS in the high CCr group. The HR of overall survival for GS compared with GC was 0.687 (95% CI 0.504–0.937) in the low CCr group. Although the total number of incidences of all Grade 3–4 non-haematological adverse reactions was higher (36.0% vs. 11.8%, p = 0.0002), the number of patients who discontinued treatment was not different (14.1% vs. 16.9%, p = 0.679) for GS compared with GC in the low CCr group. This study suggests that GS should be selected for the treatment of advanced BTC patients with reduced renal function.
AB - JCOG1113 is a randomized phase III trial in patients with advanced biliary tract cancers (BTCs) (UMIN000001685), and gemcitabine plus S-1 (GS) was not inferior to gemcitabine plus cisplatin (GC). However, poor renal function often results in high toxicity of S-1. Therefore, we examined whether GS can be recommended for patients with low creatinine clearance (CCr). Renal function was classified by CCr as calculated by the Cockcroft-Gault formula: high CCr (CCr ≥ 80 ml/min) and low CCr (80 > CCr ≥ 50 ml/min). Of 354 patients, 87 patients on GC and 91 on GS were included in the low CCr group, while there were 88 patients on GC and 88 patients on GS in the high CCr group. The HR of overall survival for GS compared with GC was 0.687 (95% CI 0.504–0.937) in the low CCr group. Although the total number of incidences of all Grade 3–4 non-haematological adverse reactions was higher (36.0% vs. 11.8%, p = 0.0002), the number of patients who discontinued treatment was not different (14.1% vs. 16.9%, p = 0.679) for GS compared with GC in the low CCr group. This study suggests that GS should be selected for the treatment of advanced BTC patients with reduced renal function.


text:
About vibrio
Image PR
Technology PR
Online Monitoring with Brandwatch
Employee Branding with Smarp
E-Mail-Marketing with AGNITAS
Social Selling with LinkedIn
"It takes twenty years to build a reputation and five minutes to destroy it." This realization of the US stock exchange guru Warren E. Buffet is more valid today than ever. Nine out of ten German executives want to know what information is available about them on the Web, but only one in three regularly follows their image on the Internet. Reputation management helps on the one hand to avoid image crises and declines in turnover or to cope with them quickly. On the other hand, it helps to improve the findability of the company on the Internet by communicating a clear value model and by strategic issue management.
The two essential elements of reputation management have thus already been named: Image building through storytelling and image protection through crisis prevention and crisis communication. Both require a forward-looking and sustainable communication policy.
Reputation management and the power of opinion in the Internet
The reputation of a company is roughly fed by two factors: on the one hand by the evaluation of the company itself and on the other hand by the evaluation of its products, services and employees, especially its management.
When it comes to obtaining information, the Internet leads the media canon. This is already evident from the enormous importance that the Internet has today for researching journalists, i.e. for the "classical" media: Almost 50 percent of journalists today discover their topics on Twitter, and almost 40 percent each on Facebook or other social networks.
About 40 percent of media workers also do research on YouTube. And among consumers, i.e. readers and viewers, the situation is no different: 70 percent of young adults visit portal sites (such as Google News), 60 percent visit websites of TV stations, 50 percent visit online offerings of online opinion makers (e.g. bloggers), 40 percent visit online offerings of traditional newspapers.
The strong power of the web is fuelled by rating portals and other online platforms. More and more consumers are avoiding traditional advertising. It therefore makes sense that around 50 percent of all consumers take personal recommendations into account when making purchasing decisions.
Among online users, this proportion is as high as 90 percent. This increases the relevance of rating pages. The employer rating portal kununu must also be mentioned in this context. Today, qualified new employees who do not use this portal to pre-select their favourite employers are increasingly seldom recruited.
Reputation management and image communication
As part of modern social monitoring, vibrio integrates three monitoring concepts:
Issue Monitoring
The topic analysis covers the topics of the time discussion in the industry or in the business environment.
Issue monitoring provides the topics on which vibrio brings its customers into conversation and into the media.
Stakeholder monitoring
The partner analysis records the statements of the partners and relevant multipliers (media, social media opinion leaders). We try to establish direct partnerships with the new opinion makers in blogs and on Facebook as well as with journalists.
The key players relevant to the customer are defined on the basis of existing relationships, but also with tools such as "SocialBro" and "Blogoscoop".
The brand analysis records statements about company and product brands in print media, on the Internet and in social media. This means that we become aware of communication crises at an early stage.
An example of stakeholder qualification using the tool Audiense
Successful reputation management via the Internet and social media requires clearly defined processes. These range from Google-optimized press releases and alert processes in monitoring to established blogger and Twitterati programs and social media events.
Reputation management and crisis communication.
"When the crisis comes, it's usually too late." This sentence is doubly valid: On the one hand, forward-looking image communication on the Internet is very helpful in avoiding crises. The more established a brand is on the web, the more difficult it will be for critics and trolls to dominate online communication: Attacks that Google cannot find will not trigger a crisis! On the other hand, a pre-defined crisis strategy makes it easier to react to sudden crises.
Internal responsibilities and communication channels, partly also concrete contents and statements, can and should be defined before a crisis occurs. Then typical reputation crises, such as the ones that follow, can be expected with relative reassurance.
The Example "The Dogs of Ukraine"
At the end of 2011, UEFA sponsors such as adidas, Carlsberg, McDonald's, Castrol, Canon, Sharp, Continental, Coca-Cola and Hyundai published thousands of postings on Facebook pages with protests against alleged dog killings in Ukraine, the venue of the European Football Championship 2012.
Under headings such as "Football on Bloody Turf", pictures and videos of poisoned dogs in agony, mobile incinerators and pits with dog bodies were shown. The sponsors of the European Championship were blamed for this scandal: Whoever supports the EM as a sponsor also supports the dog killings in the host country, which are carried out to present the country immaculately and cleanly.
The branded companies reacted very differently to this "Shitstorm": Hyundai didn't even notice the protests on its own site at first, then deleted the comments and abandoned the site. Continental responded and then deleted "unfair" criticism and left others untouched. Adidas took up the criticism, took a stand for the critics and positioned itself as their spearhead.
The further course of the campaign has shown some basic rules for reputation management:
Responding quickly is a must. That's why professional crisis PR is needed.
There are always several appropriate strategies.
Every strategy must be credible and fit into the overall picture of corporate communications.
Sometimes you can accept criticism.
You always have to take criticism seriously.
In any case, you have to show willingness to discuss.
You can defend yourself against unfair criticism.
The Example "Mammut"
The importance of general credibility is also particularly well illustrated by the example of the Shitstorm around the Swiss outdoor goods manufacturer Mammut: In 2011, Mammut committed itself to a campaign by the umbrella trade association Economiesuisse against a new CO2 law.
The starting point was a corresponding statement on the association's website. In the past, however, Mammut had positioned itself strongly in ecological terms. That's why a customer got annoyed and formulated this annoyance in a short tweet, which in turn led to numerous other tweets and critical comments on Mammut's Facebook page.
The company had a proper monitoring system and responded quickly to the postings with several comments. But Economiesuisse's support of the campaign was justified with ready-made text modules. Also, the justification postings were not signed by name. As a result, the critics accused Mammut of hiding behind anonymous structures and being unaware of the accusations.
In fact, you have to react in such situations with individual statements. And a personal sender must always be recognizable. Critics want to talk to people, not anonymous companies. Above all, however, support for the Economiesuisse memorandum stood in sharp contrast to the ecological image that has been cultivated to date. The credibility conflict was foreseeable. After several days, Mammut declared his withdrawal from the list and publicly apologized.
The Example Bratwurstmanufaktur
A particularly beautiful learning example to the topic crisis communication realized vibrio chief Michael Kausch some time ago with students of the Fachhochschule Würzburg-Schweinfurt. In the Internet the behavior of a typical Trolls was shown. The students should thereupon find out the action possibilities of an attacked enterprise. Here it goes to the Troll role play.
Even when formulating and communicating an eco-oriented corporate mission, one must be aware that campaigns that place profit orientation above aspects of sustainability and environmental protection can never be considered for one's own company again.
It must therefore be clarified at an early stage whether an environmentally oriented sustainable corporate policy can be implemented. In case of doubt, it is better to do without quick image successes as an environmentally oriented company than to expose oneself to credibility deficits.
(Translated with Deepl.com)
Summary: What is Reputation Management?
Reputation management combines active image communication, which also uses the Internet and social media, with a forward-looking crisis strategy and rapid crisis communication. It combines modern issue, stakeholder and brand monitoring as part of a storytelling strategy. It requires long-term personal contacts to traditional and new social media.
Reputation management is theme-driven. That is why modern PR agencies are the right partners for every form of reputation management.
We continuously publish numerous concrete and current tips and tricks on reputation management in our newsletter, on our blog and in various lectures.
vibrio München
vibrio. Kommunikationsmanagement Dr. Kausch GmbH
Rundfunkplatz 2
Ansprechpartner Dr. Michael Kausch
vibrio Zürich
vibrio. Repräsentanz Schweiz
Jenni Kommunikation
Südstrasse 85/PF
41 (44) 388 60 80
Ansprechpartner Urs Jenni
vibrio Wien
vibrio Repräsentanz Österreich
Kunigundbergstraße 43
A-2380 Perchtoldsdorf
Ansprechpartnerin Martina Limlei
© vibrio 2018

redpajama_set_name: RedPajamaCommonCrawl


text:
6 Top-Ranked Internet Stocks to Snap Up Heading Into 2021
Radhika Pujara
December 3, 2020, 9:12 AM ·8 min read
Internet stocks are riding on the massive demand for digital transformation and cloud-computing services, courtesy of the work-from-home, online learning and remote health diagnostic trends.
The significance of the Internet amid the pandemic cannot be underestimated as it emerged as a beacon of light helping people cope with the new normal. Economies globally are enduring the ordeal with the help of services such as video conferencing, gaming and online learning, to name a few.
The confidence surrounding Internet stocks can be ascertained by the robust performance of Invesco NASDAQ Internet ETF (PNQI), which has rallied 57.7% on a year-to-date basis compared with the SPDR S&P 500 ETF's (SPY) gain of 14%.
Notable Factors to Boost Internet Stocks Through 2021
The optimism stemming from vaccine approvals has bolstered confidence no doubt. But, until and unless vaccines are democratized, the practice of social distancing is here to stay.
In a bid to contain the virus spread, the usage of Internet-of-Things-based services, robotics, e-commerce, social media platforms, contactless payment and online delivery solutions has increased worldwide.
Demand for SaaS-based (or Software as a Service) applications pertaining to employee collaboration, telehealth care, cybersecurity, infrastructure monitoring, asset performance management and human capital management solutions, amid accelerated deployment of 5G, remains significantly high.
Additionally, the stay-at-home wave has increased user engagement across social media platforms as well as online gaming, music and video streaming services.
Also, the reopening of theaters, parks and event spaces following the easing of lockdowns is anticipated to cause a strong 20.7% rebound in entertainment digital ad spending to $8.48 billion in 2021, per eMarketer data.
Moreover, per another eMarketer update, increasing investments in mobile, video ads, connected TV (CTV) and programmatic transactions are expected to facilitate a recovery in 2021, with U.S. programmatic digital display spending set to hit $79.61 billion.
Winning Criteria
Given the promising backdrop, we zero in on six Internet-focused stocks that are well-poised to grow in 2021.
Apart from strong fundamentals, each of these stocks has a favorable combination of a Growth Score of A or B, and a Zacks Rank #1 (Strong Buy) or 2 (Buy). You can see the complete list of today's Zacks #1 Rank stocks here.
Markedly, growth investors are primarily focused on stocks with aggressive earnings or revenue growth, which should boost their stock price in the future
By concentrating on Zacks Rank #1 or 2 stocks, growth investors can easily screen for companies, utilizing the Zacks Stock Screener, exhibiting these stellar growth rates and their likelihood of continuing. Per the Zacks proprietary methodology, stocks with these favorable combinations offer good investment opportunities.
Notably, each of the six companies have seen positive earnings revisions for both the current and the next fiscal year in the past 30 days.
Year-to-Date Performance
The Trade Desk TTD is poised to gain from a projected solid uptick in programmatic ad buying in 2021. Moreover, the growing clout of digital content is bolstering the utilization of its inventory across all forms of CTV.
Further, a recovery in ad demand on an improving spending scenario is expected to drive the top line for this Zacks Rank #1 company.
The company has a Growth Score of B. The Zacks Consensus Estimate for its 2020 earnings is pegged at $4.23 per share, which has been revised 44.9% upward in the past 30 days. For 2021, the consensus mark for earnings has moved up 18.8% to $4.49 per share over the same time frame.
NIC Inc. EGOV is benefiting from the growing clout of digital government services aimed at enabling governments to leverage the Internet to reduce costs and offer advanced services to businesses and citizens.
Moreover, product-mix shift to SaaS and new contract wins across the States of Iowa and Florida, remain the key catalysts. Further, the company is benefiting from the continued momentum in COVID-19 testing partnerships.
This Zacks Rank #1 company has a Growth Score of B. The Zacks Consensus Estimate for its 2020 earnings is pegged at $1.02 per share, having been revised 1% upward in the past 30 days. For 2021, the consensus mark for earnings has moved up 3% to $1.03 per share over the same time frame.
Dropbox DBX has been gaining from the evolving workspace demand for seamless enterprise communication tools.
The company offers a platform that enables users to store and share files, photos, videos, songs and spreadsheets. Solid demand for cloud storage, triggered by the coronavirus-led work-from-home wave, has been acting as a tailwind for this Zacks Rank #2 company.
Further, integration with leading applications like Zoom Video, Slack and Atlassian is likely to expand the Dropbox paying-user base over the long run.
Dropbox has a Growth Score of A. The Zacks Consensus Estimate for its 2020 earnings is pegged at 88 cents per share, having been revised upward by 14.3% in the past 30 days. For 2021, the consensus mark for earnings has moved up 9.9% to $1.00 per share over the same time frame.
Digital Turbine APPS is benefiting from robust demand for its cloud-based mobile software offerings as enterprises continued the shift from on-premise to cloud environments, especially amid the coronavirus-led lockdown.
Prospects appear bright, given a diversified partner base, a large content business partner and rollouts with newer international partners, which are expected to drive the top line.
This Zacks Rank #2 company has a Growth Score of A. The Zacks Consensus Estimate for its fiscal 2021 earnings has risen 1.6% to 63 cents per share in the past 30 days. Over the same timeframe, the consensus mark for fiscal 2022 earnings has climbed 7.5% to 86 cents per share.
Shopify SHOP is riding on an exponential surge in buying of essential items due to COVID-19-induced lockdowns and shelter-in-place guidelines. Moreover, the robust performance of Shopify Shipping, Shopify Payments and Shopify Capital is a key catalyst for this Zacks Rank #2 company.
Furthermore, the strong uptake of new merchant-friendly applications amid an evolving retail environment and an e-commerce boom bodes well. Also, partnerships with Walmart and Facebook are expected to expand the merchant base. Initiatives aimed at international expansion remain noteworthy.
Shopify recently announced that brands on its platform hit $5.1 billion in sales on Black Friday/Cyber Monday 2020 weekend, up 76% year over year. Shopify platform had generated sales of $2.4 billion alone on Black Friday.
The company has a Growth Score of B. The Zacks Consensus Estimate for 2020 earnings has moved upward by 1.6% to $2.51 per share in the past 30 days. For 2021, the consensus mark for earnings has moved up 4.3% to $2.45 per share over the same time frame.
Wayfair W is witnessing strong acceleration in new and repeat customer orders. Also, an expanding active customer base and strength in the company's direct retail business are positives.
The stay-at-home wave is encouraging expenditure on upgrading living spaces. This holds promise for this Zacks Rank #2 company, which engages in the e-commerce business, offering furniture, décor, decorative accents, housewares, seasonal décor, and other home goods.
Moreover, the company is aggressively investing in international regions in order to bolster presence and expand in-house-brand offerings.
Wayfair has a Growth Score of B. The Zacks Consensus Estimate for its 2020 bottom line is pegged at $4.36 per share, having revised upward by 61.5% in the past 30 days. For 2021, the consensus mark for earnings has moved up 79.7% to $2.21 per share over the same timeframe.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research SherazMian hand-picks one to have the most explosive upside of all.
You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
NIC Inc. (EGOV) : Free Stock Analysis Report
Wayfair Inc. (W) : Free Stock Analysis Report
Shopify Inc. (SHOP) : Free Stock Analysis Report
The Trade Desk Inc. (TTD) : Free Stock Analysis Report
Dropbox, Inc. (DBX) : Free Stock Analysis Report


Chad James Buchanan Talks "Inhumans" and more | DA MAN MagazineChad James Buchanan Talks "Inhumans" and more – DA MAN Magazine – Make Your Own Style!
Here, Buchanan shares his journey with both titles along with the passion that drives him with DA MAN.
DA MAN: Hi, Chad; thank you for making the time for us. So, how are you doing?
Chad James Buchanan: Life is absolutely wonderful and I've never felt so truly grateful for all the opportunities I've been given. I feel like there is magic in the air. I'm in a phase of my life where I am learning so much about my craft, myself, and life in general. Things are moving fast and I'm really enjoying each moment along the way.
DA MAN: So, we've just learned that you are joining the cast of Marvel's "Inhumans." Can you tell us how this came about?
Chad James Buchanan: There are no shortcuts in this business. This was a three step audition process. First came the cattle-call, then the callback and then there was an additional Marvel direction for the third and final callback. It all happened in a three day time-span. It was like all of the sudden I woke up and found myself in Oahu, Hawaii.
DA MAN: So far, are there any details about the show or about your character that you can share with us? Or maybe you can give us a hint or two?
Chad James Buchanan: For good reasons, Marvel keeps their material in this universe confidential. I've never seen so much privacy, and secrecy. I don't even get the scripts—just my sides! That being said, I have uncovered what's going on through some of the crew and cast mates, but I am not at liberty to say. You'll just have to wait and see.
DA MAN: Fans of the Marvel Cinematic Universe have long hailed the franchise as doing an extremely good job in casting. What, do you think, was it that the studio saw in you when they picked you?
Chad James Buchanan: I've put in years and years of hard work to become confident at what I am doing. But at the end of the day, I always walk into an audition room, do my thing, and then put it all behind me. To be honest, I have no idea what they saw in me. But I couldn't be more excited to be a part of the MCU. The content Marvel has been creating has been of incredible quality and the fans backing the MCU are unparalleled. I feel so grateful to be a part of this special project.
DA MAN: We might be getting ahead of ourselves a bit here, but do you think that being part of the MCU will lead to new opportunities further down the road?
DA MAN: Within nearly a decade, the Marvel Cinematic Universe grew from one movie into a franchise encompassing dozens of titles and God knows how many tie-ins. Some see this as a great thing; others fear that Marvel has spread itself too thin. What is your take on this?
Chad James Buchanan: Marvel has been rolling out one hit after another. There is a brilliant team behind the MCU, in both their television and film departments. I trust that as long as the content continues to be of the utmost quality, with all of the heart and depth among the bravado, the MCU will continue to thrive.
DA MAN: Before your involvement in the MCU, however, you were known primarily for playing Hunter Morgan in "Star." And not too long ago, the show ended with a bang—and your character's death. What was it like closing that chapter of your career?
Chad James Buchanan: Honestly, Hunter's death on "Star" was one of the most incredible things that ever happened to me. It was quite moving to see the reaction from the crew and cast mates. I received so much love and respect as a sendoff from the show. I knew that my character Hunter Morgan was destined to die from the beginning and Lee Daniel ["Star" co-creator, executive producer, director and writer] gave me a very loving call to break the news. I will forever be grateful to that man for giving me the opportunity to play such a dynamic and tragic character. The most surprising thing of all was the outburst from the fans across social media in regards to my death. I try not to pay too much attention to the media, but I couldn't help but gasp as the outcries continued to pour in from all over the world. It's a beautiful thing to be respected for your work.
DA MAN: You are quite vocal on the issue of domestic violence, which is a central theme of "STAR." You've even pointed out how your character, Hunter, "is an abuser and he's f***** up." Where does this passion come from?
Chad James Buchanan: I've witnessed this kind of abuse first hand in my own life. It breaks my heart to know that this happens to many women every single day. There is no just means for that kind of behavior ever and I will not tolerate it. "Star" gave me a platform and the resources to make a difference and I used it. I will continue to speak out against domestic violence and advocate women's rights. I think my deep respect and love for women and all they have to offer come from my mother. She is my hero and one of the most inspiring people I know.
DA MAN: As you mentioned earlier, despite Hunter clearly being a messed up character, it isn't hard to find viewers who are rooting for him. Why do you think is this so? And do you find this troubling?
Chad James Buchanan: I did my best to add dimension to Hunter and to serve the writing as best as possible. In life, there are no purely "good" or "bad" persons. Hunter is not evil. Hunter didn't do the things he did because he wants to be a bad person. In fact, he wants to face his demons, and he wants to love and ultimately be happy. He really does, like anyone else, want to find happiness and to find true love. But unfortunately, Hunter never learned how to love and that is the source of his troubles. I feel bad for the guy, really. I pity him. I think people connected to Hunter's struggles. It doesn't trouble me that they rooted for him. Fortunately, people were able to see past the monster and see the heart in the character. I think I did my job!
DA MAN: Did you find it difficult, or in any way challenging, to step into the shoes of a character like Hunter?
Chad James Buchanan: No. I do not judge my characters. I am a storyteller. I do not fear anything in the confines of storytelling. It is not my job to judge. It is only my job to serve the writing, the vision behind the project, and to stay true to, well, the truth.
DA MAN: What do you miss the most about being on "Star"?
Chad James Buchanan: I miss working with Benjamin Bratt. He is a good man and friend. I admire him for his qualities beyond being a movie star. I learned much from him.
DA MAN: So, you've just wrapped up a major role in a very profound TV show and you're now working on another momentous production. What's going on in your head right now?
Chad James Buchanan: Sometimes there are these euphoric moments in which I become aware that I am living my dream. But at the end of the day I haven't changed a bit; I'm just feeling so incredibly lucky and grateful.
DA MAN: You've been involved in quite a few high profile TV shows before "Star," such as "Glee" and "Grey's Anatomy." Based on your experience, what would be your dream project?
Chad James Buchanan: I'm very interested in working with incredible minds. I want to work with smart storytellers who share the same passion for character, story, and truth. I really want to work with some of the great directors of our time and to tell stories that move audiences emotionally. I have my eyes on the big screen.
DA MAN: In the world of filmmaking, who are the people (your fellow actors, directors, producers, stunt coordinators—anyone, really) who you look up to the most?
Chad James Buchanan: My favorite actor of all time is Paul Newman. I look up to him, not only for the work he did as an actor, but for the man he was off-screen. A few of my favorite directors are Stanley Kubrick, Francis Ford Coppola, Martin Scorsese, Quentin Tarantino and Christopher Nolan.
DA MAN: How about in life in general? Which living person do you most admire?
Chad James Buchanan: My mother. She raised us three kids all by herself and gave us abundance through her love and care. She encouraged me to chase my dreams and for that I owe it all to her.
Chad James Buchanan: I moved to New York City when I was 16. Modeling paid my bills while I attended acting classes and programs. It was a hard time of my life that I didn't particularly enjoy. However, I was fortunate to travel the world at a very young age.
DA MAN: What was it then that made you take the plunge into acting?
Chad James Buchanan: I always loved film growing up and had a very deep passion for psychology and why people behave the way they do. Like, what makes a person tick, ya know? I landed my first guest star role on "The Glades". This was also my first audition ever! It was a fake-it-till-you-make-it kind of thing. I had no idea what I was doing. [Laughs] When I finally got a taste for what it was like to be on set I moved to Los Angeles and never looked back.
DA MAN: Looking back at your career, what would you say has been your greatest achievement so far?
Chad James Buchanan: My greatest achievement thus far has probably been some of my performances in theater. There have been certain moments which have transcended my own capacity for understanding; performances in which you lose yourself in character and in the moment of the scene. Then, when you finally take a conscious step back and realize that the audience is crying or hanging on your every action. Ah, there's nothing like it. I hope to have moments like these on the big screen.
DA MAN: It would certainly seem that you have a lot on your plate for the time being. Do you enjoy being busy?
Chad James Buchanan: I enjoy being busy. I thrive in the routine and hard work of it all. Only recently have I realized the importance of relaxing, letting go and allowing time to enjoy the fruits of the labor.
DA MAN: On a perhaps related note, when—or where—do you feel the happiest?
Chad James Buchanan: I feel the happiest with my girlfriend, somewhere by the sea. Perhaps, on a beach. In Hawaii.
DA MAN: Besides acting, what else are you passionate about?
Chad James Buchanan: I'm very passionate about helping the less fortunate achieve greatness. I believe we all have the power and capacity to make our dreams a reality. I'd love to help as many people as I can to truly realize this and break free of fear. To help people transform physically, mentally, and spiritually. Thus, I am passionate about fitness, nutrition, travel and life's deeper undercurrent.
DA MAN: Building on what you have achieved so far and what you will do in the near future, how do you want to be known as in the years to come?
Chad James Buchanan: All I want is to be known as a truly good man who did many great things.
DA MAN: Final question: What is your motto?
Chad James Buchanan: All love.


text:
Home / Responsible Investment
Asset managers have a major role to play in helping solve some of the most pressing problems the world currently faces. As a link between the providers of funding and those who need it, we are in a privileged position…
In 2019, Unigestion developed proprietary company and country ESG scores to further integrate ESG criteria into the investment process. The scores provide comprehensive measures of companies' and countries' efforts in terms of ESG considerations…
We believe in the importance of being an active shareholder. We exercise the voting rights on equity holdings on behalf our clients through an outsourcing arrangement with ISS, a specialist third-party proxy voting firm…
We are signatories to a number of global initiatives to support and promote responsible investing.
In the spirit of transparency, we have provided a number of our Responsible Investment policies, reports and resources in this section.
Institutional: (i) Financial intermediaries as defined in the Banking Act (BankA), the Financial Institutions Act (FinIA) and the Collective Investment Scheme Act (CISA); (ii) insurance companies as defined in the Insurance Act (ISA); (iii) foreign clients subject to prudential supervision as the persons listed under note 3(i) and 3(ii); (iv) central banks; (v) national and supranational public entities with professional treasury operations.
Intermediary: (i) Public entities with professional treasury operations; (ii) occupational pension schemes with professional treasury operations and other occupational pension institutions providing professional treasury operations; (iii) companies with professional treasury operations; (iv) large companies; (v) private investment structures with professional treasury operations created for high-net-worth retail clients.
Retail: any other type of investor.
The content of this website is published by Unigestion SA, Av. de Champel 8C, 1211 Geneva, Switzerland, a fund management company licensed by the Swiss Financial Market Supervisory Authority (FINMA).
Before continuing, please read the LEGAL INFORMATION below relating to the terms of use of the Unigestion website (the "Site")
1. Access to the Site
Access to the Site is not allowed to persons coming under a jurisdiction (through their domicile, nationality or any other manner) in which its publication or availability would constitute a violation of the existing laws and regulations. If you come under such a jurisdiction, you are not authorised to continue and must leave the Site immediately. If you do not come under such a jurisdiction, you can access the Site after having read and accepted the following conditions and terms.
2. No recommendation
The information disseminated on the Site does not constitute a recommendation to make or liquidate an investment or carry out any other transaction. Any investment decision must be based on an analysis of the risks (including any legal, regulatory, tax or other consequence) related to the investment as well as on the relevant and specific advice of an independent professional.
The information provided on this website constitute an advertisement pursuant to the Swiss Financial Services Act ("FinSA") and its implementing ordinance. The information provided on this website does not constitute an offer of any financial instrument. No financial services are provided through this website, such as an offer or a solicitation of an offer to purchase or sell financial instruments, or investment advice. All information is of a generic nature. Financial services, in the meaning of FinSA, may only be provided to you after you have established contact with us and we have identified you and classified you according to your investor status.
3. No guarantee
The information and opinions disseminated on the Site are provided by Unigestion based on public information, data developed internally as well as other reputedly reliable sources. Although Unigestion has endeavoured to ensure that this information is as accurate and comprehensive as possible at the time of its publication, no express or tacit guarantee is given in this respect. The content of the Site is likely to be modified at any time and without notice. Only the latest versions of the prospectuses, key investor information documents (KIID) as well as the annual and semi-annual reports of investment funds can be considered as an official fund publication on the basis of which investment decisions are taken.
4. Performances and risks
Past performance is no guarantee or indicator of future results. The value of investments may go up as well as down. Like any investment, an investment with Unigestion has risks, notably the risk of losing the amount invested.
The risk factors of the financial instruments presented on this Site are described in the fund prospectuses.
5. Local legal restrictions and specific information
The Site is not intended for persons residing in a country in which the distribution of the financial products presented therein would contravene local laws and/or regulations. Such persons must not access this Site. It is your responsibility to ensure that you are authorised to access it. This Site contains information relating to a large number of financial instruments registered and managed in different jurisdictions. Therefore, you will have to indicate your place of domicile before being able to access the information relating to the said products. Please take note of the fact that private investors' access to the said information shall be limited to the financial instruments authorised for sale to the public in their country of domicile.
None of the financial products mentioned on this Site are or shall be registered according to the "United States Securities Act" of 1933, as amended. Similarly, the investment funds mentioned on this Site are not registered according to the "United States Investment Company Act" of 1940, as amended, and are not destined to be registered. Consequently, the above-mentioned investment funds must under no circumstances be offered or distributed: (i) on the territory of the United States of America, in one of the States or in another political sub-division of the United States, or (ii) to, for the benefit or in favour of US nationals (as defined in Regulation S of the "United States Securities Act" of 1933).
The fund Contract, the Prospectus, the Key Investor Information Document(s) as well as the latest annual and semi-annual reports of Unigestion Swiss Equities, a Swiss collective investment scheme organized as a contractual fund under Swiss law, can be obtained free of charge and upon request from the fund's management company, Unigestion SA, 8c Avenue de Champel, 1206 Geneva, and from the distributors of the fund.
The Prospectus, the Key Investor Information Document(s) as well as the latest annual and semi-annual reports of Uni-Global, a collective investment scheme organized under the laws of Luxembourg can be obtained free of charge and upon request from the fund's management, the distributors or from the representative of the fund in Switzerland being Unigestion SA, 8c Avenue de Champel, 1206 Geneva. HSBC Private Bank (Suisse) SA, Quai des Bergues 9-17, 1201 Geneva acts as the paying agent in Switzerland of the fund.
The Prospectus, the Key Investor Information Documents, the Articles of Association as well as the latest annual and six-monthly reports of the Uni-Global mutual fund can be obtained free of charge and upon request from the management company, distributors or the local representative: Erste Bank der österreichischen Sparkassen AG, Brandstätte 7-9/1. Stock A-1010 Vienna.
Unigestion (UK) Ltd fully supports the principles of the Stewardship Code (the "Code") issued by the Financial Reporting Council in the United Kingdom. Unigestion recognises that the Code is a key component of sound corporate governance and reinforces the responsibilities incumbent on asset managers to ensure that they engage in an effective and constructive dialogue with portfolio management companies in order to best serve the interests of their clients.
Consult the document Unigestion (UK) Limited's UK Stewardship Code
As a firm regulated by the FCA Unigestion (UK) Ltd is required to have a written procedure for the effective consideration and proper handling of complaints and conflicts of interests. Unigestion UK Limited's Complaint Management and Conflicts of Interest Policies and the accompanying procedures are detailed in the following documents: Unigestion UK Complaints Policy and Unigestion UK Limited Conflicts of Interest Policy.
Under its legal and regulatory obligations, Unigestion Asset Management (France) SA has put in place a policy relating to the processing of complaints.
For more information on this policy, please refer to the document Complaint Handling Policy.
The Unigestion Group carries on business in Canada through Unigestion Asset Management (Canada) Inc. (UAMC) which is registered in every province of Canada (except Newfoundland and Labrador and Prince Edward Island) as a portfolio manager and exempt market dealer and in the provinces of Ontario and Quebec as an investment fund manager. The services and products described herein are offered only in those jurisdictions and to those persons where and to whom they may lawfully be offered.
In particular, if you access this Site and you are domiciled in Canada, you confirm to be an accredited investor or other prospectus exempt investor.
6. Taxation
Tax treatment depends on the personal situation of each investor and can be subject to changes. Before taking any investment decision, investors are recommended to resort to the specific advice of a tax professional.
Unless indicated otherwise, Unigestion is the owner, or holder of the rights, of all the components that make up this Site, notably the data, charts and drawings. Any total or partial reproduction, representation, distribution or redistribution of the content of this Site through whatever process without the prior express authorisation of Unigestion is prohibited.
This Site may contain hyperlinks to other websites. Navigation to such links is undertaken at your own risk. Unigestion refuses to accept any liability regarding the content and any potential damage caused during visits to sites to which this Site leads through hyperlinks. Users visit the other sites under their own responsibility and at their own risk.
Users are informed that during their visits to the site, a cookie can be automatically installed and be stored temporarily in the memory or on their hard disk. A cookie is a component that cannot be used to identify the user but serves to record information relating to the user's navigation on the website. Cookies are used on the Site solely to record information relating to the user's navigation on the Site in particular browsing behavior for statistics purposes and to offer you targeted advertising.
Users of the site acknowledge that they have been informed of this practice and authorise Unigestion to use it. They can disable this cookie through parameters contained within their navigation software.
This website uses Google Analytics, a web analytics service provided by Google, Inc. ("Google"). Google Analytics uses "cookies", which are text files placed on your computer to help the website analyse how visitors use the site. The information generated by the cookie about your use of the website (including your IP address) will be transmitted to and stored by Google on servers in the United States. Google will use this information for the purpose of evaluating your use of the website, compiling reports on website activity for website operators and providing other services relating to website activity and internet usage. Google may also transfer this information to third parties where required to do so by law, or where such third parties process the information on Google's behalf. Google will not associate your IP address with any other data held by Google. You may refuse the use of cookies by selecting the appropriate settings on your browser, however please note that if you do this you may not be able to use the full functionality of this website. By using this website, you consent to the processing of data about you by Google in the manner and for the purposes set out above.
You can prevent Google's collection and use of data (cookies and IP address) by downloading and installing the browser plug-in available under https://tools.google.com/dlpage/gaoptout?hl=en. Further information concerning the terms and conditions of use and data privacy can be found at http://www.google.com/analytics/terms/gb.html.
10. Terms and conditions
Users are informed that the personal data they share with Unigestion SA is used to provide the services to which they have enrolled or subscribed, and we do not use this data for any other purpose. To provide users with these services, we may share this data with third parties, including affiliated companies and third-party service providers, providing data processing, data storage, marketing, statistics or administrative services within Switzerland, European Union member states, and other foreign jurisdictions, including in jurisdictions whose legislation may not provide the same level of data protection as in Switzerland or in the European Union, such as the United States, Canada and Singapore. Unigestion SA, however, has implemented high-standard internal data protection rules so as to ensure compliance with applicable data protection laws and provide an adequate level of protection in relation thereto.
Users are informed that they can withdraw their consent at any time by using the UNSUBSCRIBE feature of the service, or by sending an email to: clients@unigestion.com.


text:
Home › Song Of The Day › Song Of The Day: The Last Detail, "Killing Time"
Song Of The Day: The Last Detail, "Killing Time"
By Joseph Kyle • October 4, 2019
One of last year's delights was the surprise reappearance of Erin Moran, better known as A Girl Called Eddy. She resurfaced with a new band, The Last Detail, with Mehdi Zannad of Fugu, and the album sounded exactly what you wanted it to sound like–electronic indie-pop with a decidedly 70s singer/songwriter bent. They've parlayed that delightful self-titled debut album into a new EP, Places, featuring two album tracks and two unreleased numbers. "Killing Time" is one of those new numbers, and it's a fantastic piece of soft pop that recalls Rita Coolidge, Karen Carpenter, and k.d. lang in one fell swoop. While there's still no word on when the new A Girl Called Eddy album will appear, Places is a fine little snack to tide us over. Hopefully we won't have to wait too much longer…
Tagged as: 2019, A Girl Called Eddy, Elefant Records, Erin Moran, Fugu, Mehdi Zannad, Song of the Day, The Last Detail
« There'll Be No Sad Tomorrow: A Conversation With The Muffs' Kim Shattuck
Girl In A Girl Band (Rare Bird Books) »


text:
Q: Python script to convert snort alert to csv I'm new to python. So please support me
I want to convert from snort alert to csv with some specific value
Here are the snort alert (can read by notepad):
[**] [1:2015665:1] ET CURRENT_EVENTS NeoSploit - TDS [**]
[Classification: Attempted User Privilege Gain] [Priority: 1]
03/14-14:13:24.731076 192.168.52.10:1060 -> 67.196.50.144:80
TCP TTL:57 TOS:0x0 ID:34187 IpLen:20 DgmLen:258 DF
***A**** Seq: 0xBB770235  Ack: 0x9A83A217  Win: 0x3CB8  TcpLen: 20

[**] [1:2021076:1] ET INFO SUSPICIOUS Dotted Quad Host MZ Response [**]
[Classification: Potentially Bad Traffic] [Priority: 2]
03/14-14:13:24.845200 67.196.50.144:80 -> 192.168.52.10:1060
TCP TTL:128 TOS:0x0 ID:1442 IpLen:20 DgmLen:5880 DF
***A**** Seq: 0x9A83C2E5  Ack: 0xBB77030F  Win: 0xFFFF  TcpLen: 20

alert.full,
I want to filter some information such as Alert, Src IP, Src port, Dst IP, Dst port, Protocol DgmLen and save to a csv file.
Alert                 SrcIP          Srcport    DstIP          Dstport  Protocol   DgmLen
ET Current event...  192.168.52.10   1060       67.196.50.144    80        TCP      258
ET INFO SUSPICIOUS   67.196.50.144    80        192.168.52.10   1060       TCP      5880

A: *

*Read 6 lines to a array

*Create a dict to hold the data you want.

*Extract Column Alert from array[0]

*Extract Column SrcIP, Srcport, DstIP, Dstport, Protocol , DgmLen from array[2] and array[3]

*Write to CSV file using csv.DictWriter

redpajama_set_name: RedPajamaStackExchange


text:
GOP lawmakers struggle to close gaps in tax plan
The Treasury Department said the tax plan currently before Congress would need an assist from other Trump administration priorities to pay for itself.
By BERNIE BECKER, AARON LORENZO and SEUNG MIN KIM
"I don't think you can say at this point anything is really nailed down," Sen. John Thune (R-S.D.) said. | Zach Gibson/Getty Images
Top congressional Republicans, racing to hammer out a final tax agreement by the end of the week, have yet to make any breakthroughs on a range of key issues.
House and Senate negotiators bounced proposals back and forth over the weekend, but said Monday that they still had to find compromises on where to set the corporate tax rate, how to treat millions of businesses that aren't set up as corporations and how much of a deduction to allow for state and local taxes.
"We speak of little else these days," said Senate Majority Whip John Cornyn (R-Texas).
On the House side, Ways and Means Chairman Kevin Brady (R-Texas) deflected questions about a slew of potential trouble spots, also including the estate tax, the Alternative Minimum Tax and the fate of an existing law barring churches and other tax-exempt groups from openly politicking.
Asked Monday what differences the House and Senate had resolved, Sen. John Thune (R-S.D.) responded: "Well, nothing really.
"I don't think you can say at this point anything is really nailed down," added Thune, a member of GOP leadership and the tax conference committee working to settle the chambers' differences. "But I think the way it's shaping up right now, I feel like we're getting pretty close, and every time that we have an exchange of offers the differences are narrowing."
Morning Tax
Sign up for our tax policy newsletter and stay informed — weekday mornings, in your inbox.
Republicans are hoping to get a final tax bill to President Donald Trump's desk by Dec. 20 or even sooner, according to a source familiar with negotiations. Brady said Monday that he still expected a final vote next week, and a public meeting of the conference committee is scheduled for Wednesday.
But a compromise measure would still need to be vetted to ensure that it doesn't violate strict Senate budget rules, a process that may start in the next couple days and could offer clues about what's in a final deal. And Republicans are facing increased pressure from Democratic lawmakers to slow down the rapid conference process; Senate Democrats on the tax conference committee are demanding at least three public meetings on merging the House and Senate bills.
"We've got just a few headline issues. How we land on rate structures, breaks in the brackets are important issues," said Sen. Tim Scott (R-S.C.), another member of the conference committee.
Scott added that negotiators were still grappling with how to "sweeten the SALT" problem, referring to differences over a state and local tax write-off. One of the things they are examining is whether to allow taxpayers to deduct both property and income taxes they pay to states, cities and counties.
Republicans have been wrestling for months with that issue. After first setting out to eliminate the deduction entirely, they've had to restore a property tax write-off, up to $10,000, to satisfy GOP members from the Northeast who represent districts with high real estate taxes. But lawmakers from California, where property taxes are less of an issue, are clamoring for something on the income tax side of the equation.
The corporate tax rate remains another key sticking point. The rate is still "being discussed and debated," Thune said, along with when it would take effect.
Looming pension shortfalls to complicate next shutdown fight
By ELANA SCHOR
Both chambers have settled on a 20 percent rate — down from the current 35 percent — but the Senate has proposed delaying its implementation until 2019. And some lawmakers and administration officials have indicated a rate as high as 22 percent may be in play to cover the cost of adding provisions to guarantee enough votes for the plan.
Conservative groups reiterated their support for a 20 percent corporate rate on Monday, but at least one prominent activist didn't shut the door to a slightly higher rate.
"While there is strong, consistent support for a 20 percent rate," said Chrissy Harbin, vice president for external affairs for Americans for Prosperity, "we are going to consider these packages holistically and make a decision at that time on Friday," when they expect a final tax package to be released.
Grover Norquist, president of Americans for Tax Reform, suggested eliminating the state and local tax deduction for corporations would be preferential to setting their tax rate above 20 percent.
The talks continued as the Treasury Department released a one-page analysis on Monday that said that the GOP tax plan would need an assist from other Trump administration priorities to pay for itself. That gave ammunition to critics who have pilloried administration claims that the tax cuts would generate enough economic growth on their own to cover the cost.
Welfare reform, infrastructure spending and regulatory relief would also help grow the economy and produce an extra $1.8 trillion of revenue over the next decade, Treasury said — more than enough to offset the up to $1.5 trillion worth of tax cuts that Republicans are working to get into law. However, welfare changes and an infrastructure plan are still just in the talking stages.
POLITICO Explains: Tax reform
Treasury Secretary Steven Mnuchin has been saying for months that his department would produce an analysis that proved the tax cuts would be fully paid for, and other top Republicans like Senate Majority Leader Mitch McConnell have insisted they have no doubt that would be the case.
"The Administration has been focused on tax reform and broader economic policies to stimulate growth, which will generate significant long-term revenue for the government," Mnuchin said in a statement.
But Monday's release drew quick criticism, from both Democrats who labeled the analysis "fake math" and independent budget analysts who have long been skeptical that the tax plan would be able to pay for itself.
The Joint Committee on Taxation, in a report released Monday, found that the House tax plan would cost around $1 trillion over a decade even when accounting for economic growth, much the same as it found when examining the tax bill passed by the Senate Finance Committee.
A range of nonpartisan outside analysts — the Urban-Brookings Tax Policy Center, the Tax Foundation and the Penn Wharton Budget Model — have all reached similar conclusions.
"This Treasury report makes a mockery of dynamic scoring and analysis, which is meant to help policymakers understand how their choices will affect the size of the economy," said Maya MacGuineas of the Committee for a Responsible Federal Budget.
Sen. Elizabeth Warren (D-Mass.), who asked the Treasury inspector general to investigate Mnuchin's previous refusal to release the department's economic analysis of the GOP tax plan, called Monday's one-page analysis "pathetic."
The Treasury Department "promised an economic analysis — but this isn't it," Warren said on Twitter. "I look forward to the IG's investigation providing real answers for American families."
Colin Wilhelm contributed to this report.


Beautiful, Meteora, Greece on Great Atmosphere | Great Atmosphere.
Oh my! What you have added to my day with this post. Thank you ever so much! I shall be re-visiting this page.
Wow that is absolutely breathtaking. Beautiful photo's and a beautiful piece of history to accompany them, and I've learnt something before breakfast. Thankyou.
Both times I visited Meteora were absolutely spectacular and enchanting in so many indescribable ways. It brings me so much joy that others have been able to experience such a spiritually sacred place. Your photographs are fantastic, thank you for sharing them.
definitely on my list when I get back to Greece! great shots.


text:
Ilarion Ciobanu  (né le  à , Royaume de Roumanie aujourd'hui en Moldavie et mort le  à Bucarest Roumanie était un acteur roumain.

Biographie
S'il fréquenta l'Université nationale d'art théâtral et cinématographique Ion Luca Caragiale il en ressortit sans diplôme.

Il a joué au rugby au Dinamo Bucarest jusqu'en 1962.

Filmographie

 1966 : Les Guerriers
 1970: Michel le Brave

Liens externes

Notes et références

Voir aussi

Bibliographie

Liens externes

Naissance en octobre 1931
Décès en septembre 2008
Naissance dans le royaume de Roumanie
Acteur roumain du XXe siècle
Décès  à Bucarest
Décès  à 76 ans

redpajama_set_name: RedPajamaWikipedia


It's a familiar scene: Syria Civil Defence, also known as the "White Helmets," rushing to rescue a man covered in rubble, but unlike thousands of other videos from Aleppo, this one is staged.
"This video and the related posts were recorded by RFS media with Syria Civil Defence volunteers, who hoped to create a connection between the horror of Syria and the outside world using the viral 'Mannequin challenge.' This was an error of judgment, and we apologize on behalf of the volunteers involved," the statement read.
Would CNN Have Covered "White Helmet" Deceit Without Alternative Media's Coverage?
Of course, the alternative media has been exposing the "White Helmets" for years as perhaps one of the largest, most complex war propaganda operations conceived thus far by Western powers in their bid to sway public opinion amid regime change efforts in Syria.
Image: RSF's "apology" lacks conviction, but is full of excuses and blame.
When the recent "mannequin challenge" video was uploaded, it was the alternative media that caught it, reported on it, and brought viral attention to it. It was the alternative media that exposed the fact that a supposed "rescue organization" was staging fake videos for war propaganda value – in possible violation of the Geneva Conventions, and certainly in violation of basic ethical concerns.
It was only after the alternative media raised these concerns and cornered RFS and the "White Helmets" that establishment media platforms like CNN finally reacted to a story it likely would have otherwise ignored.
It is no wonder, then, why establishment media platforms like CNN, the Washington Post, and others are so passionately opposed to the alternative media – they are no longer setting the agenda, and are instead forced to react. Real journalism equates to reporting and honestly analyzing world events rather than contriving and spinning them – for CNN and others, they no longer possess the freedom to do the latter without consequence.
For the alternative media, successes like this, and the fact that establishment Western media has all but declared war on the alternative media should highlight the value of honest journalism and analysis. It should also be a constant reminder that fact-driven media will always win out over agenda-driven media. For the alternative media to continue to grow and be successful, it must reaffirm its dedication to fact-driven media no matter how tempting it is to do otherwise.
Tony Cartalucci, Bangkok-based geopolitical researcher and writer, especially for the online magazine "New Eastern Outlook."
I googled CNN and this and there is none of this on there just horrific pictures. Jeez how sick are you people? Need to be stopped this is fake. There should be a law. Must be Russian.


Dr. Abdulkareem Al Bekairy started the meeting with a speech in which he welcomed his fellow Deans and thanked them for their confidence in his election as Chairman of the Committee. He asked God to help the Commission in the service and development of the Faculties of Pharmacy in its various programs and academic, scientific and research plans and in the graduation of competent national competencies. Reviewed the agenda of the meetings.


Congratulations graduating seniors! You and your guests are invited to the College of Social and Behavioral Sciences Spring Convocation. This ceremony is an opportunity to celebrate your accomplishments with your classmates, family, and friends and includes a procession where you will be individually recognized.
This event is free and guest tickets are not required. Doors open at 5 pm. Seating will be on a first come, first serve basis.
The event is expected to last approximately 2.5 hours.
We ask all graduates to come carrying their regalia. You will be screened through security.
Check in for graduating seniors begins at 5 pm on the east side of the McKale Center. You must check in by 5:45 pm in order to be seated before the ceremony begins.
You must wear a cap and gown to participate in the ceremony. Caps, gowns, tassels, and stoles are available from the UA BookStores.
Professional photography will be available to purchase through GradTrak, (800) 261-2576.
No outside containers, large bags, backpacks, or parcels are allowed inside the McKale Center. All in-hand items must be placed in appropriate and approved clear bag. See the UA Clear Bag Policy.
The McKale Center is located on the UA campus at 1 National Championship Drive [link to map]. Allow for extra travel time due to heavy traffic.
Free parking will be available. Visit UA Parking & Transportation for information on parking garages and surface lots.
Accessible parking is available in the Cherry Avenue Garage next to the McKale Center. Take the second-floor walkway between the garage and McKale. Volunteers will direct guests to accessible seating options once inside.
A drop off area is also located in the parking lot east of McKale.
Do you have guests that can't make it to the ceremony? A livestream of the SBS Convocation will be available at sbs.arizona.edu/live.
If you have questions or need special assistance, contact Isabel Contreras at 520-621-8402 or imc@email.arizona.edu.
Looking for info on the University-wide commencement ceremony or other Convocation events? Visit the UA Commencement website.


In today's competitive business world it is a fundamental error to disregard customer care. The general public are no longer prepared to put up with shoddy customer service �C and why should they? We are becoming increasingly fussy with so many bad experiences under our belts it is understandable. Banks, shops and hotels alike are all businesses capable of demonstrating unacceptable levels of customer care. Companies who succeed and stand apart from the others do so partly due to a dedication to customer satisfaction. Taking phone and broadband providers as an example �C the best know that customer satisfaction is paramount and they will contact customers to ensure they are happy with services provided. If there is any connection issues or problems with the services they will stay in touch with the customer until the problems are resolved offering compensation where necessary. Their customers remain happy with the dedication displayed and when contracts christian louboutin sale end they are renewed. The unsatisfied customer goes elsewhere. One way to ensure customer satisfaction is by employing a dedicated customer service team to take care of any problems. If you have a small business and there is no need for a dedicated customer service team you should take customer satisfaction seriously and follow up any concerns. You will not christian lose your customers should any problems arise if you show a dedication to resolving them. A customer contact team can be responsible for reminding your existing customers about any products or services that they may require. Depending upon the nature of the business, your customer care team can then conduct follow-ups with the aim of ensuring customer satisfaction. Dealing with customer complaints in an appropriate manner is essential and appropriate action can turn an unhappy customer into a very happy customer who will then recommend your business because of its merits. To pay attention to detail and the have the ability to display empathy towards your customers concerns is a good place to start. It louboutin shoes on sale makes sense to send your employees on customer service funky shoes training programs as they can be taught some valuable skills to aid them if they have very unhappy customers to help. Everyone makes mistakes and it is impossible to provide 100% satisfaction guaranteed every time, however it stripper shoes is possible to correct mistakes. Customer service goes further than correcting mistakes it is essential that a customer's needs are met from the outset �C this can be carried out by preparing staff and providing the right tools and encouraging positive interdepartmental relationships. Go online and source business telephones for sale; your customer care team will require reliable equipment in order to work productively. Other equipment such as best business laptops will enable all key members of staff to remain online and capable of providing a dedicated service.


Snatam Kaur has created a series of short videos relating to her newest release, Meditation Of The Soul: Jap Ji Daily Practice and Learning Tool. In her video, "Give Your Troubles to God," Snatam shares the 5th pauri and her incredible experience with these sacred words.
Snatam continues with giving us the message behind these words: to be in a state of always singing, always listening, and always within your own being, you can give all of your troubles to the divine and take peace home with you. "Often times, we are in state of trouble, of frustration, of sadness and we don't want to give those emotions away. Instead, we want to hold on to them. Then those emotions saturate our being.
Snatam's passion for empowering people to recite Jap Ji is ignited by her hope that all of us can delve deep into the study and find the take home messages within this sacred text.
Find some great Snatam Kaur music here!


text:
Q: Creating an Algorithm From Pressing A UIButton to Change the UIView I'm creating a quiz app, and I was wondering instead of using multiple if statements, I could make an algorithm that uses an int to alternate between UIViews when you click a UIButton. With multiple if statements the code would look something like this:
IBAction NextQuestion; {

    Question++; //QUESTION IS THE int FOR THE ALGORITHM.

    if (Question==2) {
        self.view = PlayView2; //PlayView2 is the UIView I'm switching to.
        }

    if (Question==3) {
        self.view = PlayView3; //PlayView3 is the UIView I'm then switching to after the next object/UIButton is pressed.
        }

and so on...
The IBAction is connected to multiple UIButtons to change the view. The goal is I want to change the UIView algorithmically instead of multiple if statements Thanks for your help!

A: myViewsArray = [[NSArray alloc] initWithObjects: PlayView2, PlayView3, ..., PlayViewN, nil];

    -(UIView*) nextView {
       if( Question < [myViewsArray count] )
           return [myViewsArray objectAtIndex: Question++];

       return nil;
    }

A: May be switch case??
switch(Question) {
    case 2: self.view = PlayView2;
            break;
    case 3: self.view = PlayView3;
            break;
}


African Women's Leadership: Breaking Barriers to Political Participation – Lecture by Ellen Johnson Sirleaf, Former President of Liberia and Nobel Laureate.
In this lecture, Former President Sirleaf will look at the democratic traditions of the continent, present the rising generation of African women who are demanding greater inclusion in the political process, and offer contextualised solutions to foster leadership and the full participation of women in Africa's democratic future.
In 2017, former President Sirleaf was awarded the Ibrahim Prize for Achievement in African Leadership, which celebrates excellence in African leadership. Sirleaf was the first female recipient.
Please note, arrival and registration is at the Security and Staff Entrance on Cromwell Road rather than the main museum entrance.
Tickets: £20 Non-members / £17 Non-members concession / £15 Royal African Society Members. Please register at eventbrite.


When you purchase a South Alabama area home, there are processes and steps that must be followed to ensure your success. The formula outlined in the Home Buying Flow Chart below is helpful to review when you are thinking about buying a home with the Jason Will Realty Group. We'd love to explain more to you in person and you schedule an appointment to come into our Old Town Daphne AL office for a no-obligation consultation by calling 251-866-6464.
We want to represent you in all your Alabama Gulf Coast real estate transactions. When you buy a home you need someone to assist you who cares about and knows the local real estate market, a true advocate. You need someone who wants to help you find your dream home. You need a champion who delivers results, bringing knowledge and experience in real estate to the table, allowing you to reach your goal. The Jason Will Real Estate Team will be at your side at every step of the way, providing professional consultation and expert negotiation to ensure a successful home buying experience.
Our amazing new website brings state-of-the-art technology to home buyers and sellers, offering the best in online search tools and market information. The National Association of Realtors reports that over half of all home buyers are using the internet to search for homes and nearly 94% of all home buyers begin their real estate search online. Our website gives you the one tool you need to find your new property in Baldwin County, Alabama. Combining our online presence with our in-depth knowledge of our local real estate market means you will be in great hands with us.
The Home Buying Process information provided by the Jason Will Real Estate Team 251-866-6464.


text:
Humplebee
Written By: George Gissing
Narrated By: Cathy Dobson
Publisher: Red Door Audiobooks
George Robert Gissing (1857–1903) was a popular English novelist and short story writer who also worked as a teacher and tutor throughout his life.
Humplebee tells the tale of a young man of the same name who, in his youth, saves the life of his schoolfellow, Leonard Chadwick, who falls through thin ice on a winter pond. The gratitude of Chadwick and in particular his friend's wealthy industrialist father lead everyone, in particular Humplebee's parents, to assume he will from then on have a great financial benefactor. Chadwick senior even appears to promise such generosity and initially employs Humplebee as a clerk in his business.
As things transpire, the promise of generous patronage is a curse to the Humplebee family. Humplebee hates the clerkship and all the more so because to take up the position he had to forego the opening at the Natural History museum, which he would have truly loved. Humplebee's parents attempt to expand their business on the promise of the Chadwick capital, but their business fails, and Chadwick refuses to bail them out.
But Leonard Chadwick reappears on the scene and appears to be about to rescue Humplebee's fortunes. And just in the nick of time because Humplebee is in love and in desperate need of financial stability in order to propose to his beloved. And then something completely unexpected and devastating happens which puts Humplebee's character and relationship to the test....
Fiction & Literature >
by George Gissing
This title is due for release on January 30, 2015.
This title is due for release on January 30, 2015


text:
package com.atlassian.jira.plugins.dvcs.listener;

import com.atlassian.jira.plugins.dvcs.model.Organization;
import com.atlassian.jira.plugins.dvcs.service.OrganizationService;
import com.atlassian.jira.plugins.dvcs.service.remote.DvcsCommunicator;
import com.atlassian.jira.plugins.dvcs.service.remote.DvcsCommunicatorProvider;
import com.atlassian.jira.user.ApplicationUser;
import com.google.common.annotations.VisibleForTesting;
import org.slf4j.Logger;
import org.slf4j.LoggerFactory;
import org.springframework.beans.factory.annotation.Autowired;
import org.springframework.stereotype.Component;

import java.util.List;
import java.util.Map;

import static com.atlassian.jira.plugins.dvcs.listener.UserAddedEventListener.ORG_ID_GROUP_PAIR_SEPARATOR;
import static com.google.common.base.Preconditions.checkNotNull;
import static com.google.common.base.Preconditions.checkState;
import static com.google.common.collect.Lists.newArrayList;
import static com.google.common.collect.Maps.newHashMap;
import static java.lang.Integer.parseInt;
import static java.util.Map.Entry;

/**
 * Invites users who were created via the 'Create user' screen to Bitbucket teams. Selections made by the administrator
 * who provisioned this user are used to determine the list of teams and groups that users will get invited to.
 *
 * Current default teams have no impact on teams and groups that users will get invited to.
 */
@Component
public class UserAddedViaInterfaceEventProcessor
{
    private static final Logger LOGGER = LoggerFactory.getLogger(UserAddedViaInterfaceEventProcessor.class);

    @VisibleForTesting
    static final String DVCS_TYPE_BITBUCKET = "bitbucket";

    private static final String ORG_ID_GROUP_DELIMITER = ":";

    private final DvcsCommunicatorProvider dvcsCommunicatorProvider;

    private final OrganizationService organizationService;

    @Autowired
    public UserAddedViaInterfaceEventProcessor(DvcsCommunicatorProvider dvcsCommunicatorProvider,
            OrganizationService organizationService)
    {
        this.dvcsCommunicatorProvider = checkNotNull(dvcsCommunicatorProvider);
        this.organizationService = checkNotNull(organizationService);
    }

    public void process(ApplicationUser user, String serializedUISelection)
    {
        checkNotNull(user != null, "Expecting a non-null user");
        checkNotNull(user.getEmailAddress() != null, "Expecting a non-null email address for the user");
        checkNotNull(serializedUISelection != null, "Expecting a non-null serialized UI selection");

        if (serializedUISelection.trim().isEmpty())
        {
            return;
        }

        Map<Integer,List<String>> groupsByOrganizationId = parseSerializedUISelection(serializedUISelection);
        inviteUserToOrganizations(user, groupsByOrganizationId);
    }

    private Map<Integer, List<String>> parseSerializedUISelection(String serializedUISelection)
    {
        final Map<Integer, List<String>> groupsByOrganizationId = newHashMap();

        for (String orgIdGroupPairStr : serializedUISelection.split(ORG_ID_GROUP_PAIR_SEPARATOR))
        {
            String[] orgIdGroupPair = orgIdGroupPairStr.split(ORG_ID_GROUP_DELIMITER);
            int orgId = parseInt(orgIdGroupPair[0]);
            String group = orgIdGroupPair[1];

            List<String> groupsForOrgId = groupsByOrganizationId.get(orgId);
            if (groupsForOrgId == null)
            {
                groupsForOrgId = newArrayList();
                groupsByOrganizationId.put(orgId, groupsForOrgId);
            }

            groupsForOrgId.add(group);
        }

        return groupsByOrganizationId;
    }

    private void inviteUserToOrganizations(ApplicationUser user, Map<Integer, List<String>> groupsByOrganizationId)
    {
        DvcsCommunicator dvcsCommunicator = dvcsCommunicatorProvider.getCommunicator(DVCS_TYPE_BITBUCKET);
        for (Entry<Integer, List<String>> entry : groupsByOrganizationId.entrySet())
        {
            Integer orgId = entry.getKey();
            List<String> groups = entry.getValue();

            Organization organization = organizationService.get(orgId, false);
            if (organization == null)
            {
                LOGGER.warn("Skipped inviting user {} to groups {} in organization with id {} because such organization does not exist",
                        new Object[] {user.getUsername(), groups, orgId});
                continue;
            }

            checkState(DVCS_TYPE_BITBUCKET.equals(organization.getDvcsType()), "Expecting Bitbucket organizations only");
            LOGGER.debug("Inviting user {} to groups {} in organization {}",
                    new Object[] {user.getUsername(), groups, organization.getName()});
            dvcsCommunicator.inviteUser(organization, groups, user.getEmailAddress());
        }
    }
}

redpajama_set_name: RedPajamaGithub